Treatment persistence and cost-effectiveness of latanoprost/latanoprost–timolol, bimatoprost/bimatoprost–timolol, and travoprost/travoprost–timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database

References

• KingmanSGlaucoma is second leading cause of blindness globallyBull World Health Organ20048288788815640929
   PubMed Web of Science ®Google Scholar
• FechtnerRDWeinrebRNMechanisms of optic nerve damage in primary open angle glaucomaSurv Ophthalmol19943923427974188
   PubMed Web of Science ®Google Scholar
• BunceCWormaldRLeading causes of certification for blindness and partial sight in England & WalesBMC Public Health200665816524463
   PubMed Web of Science ®Google Scholar
• WeihLMNanjanMMcCartyCATaylorHRPrevalence and predictors of open-angle glaucoma: results from the visual impairment projectOphthalmol200110819661972
   PubMed Web of Science ®Google Scholar
• RudnickaARMt-IsaSOwenCGVariations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysisInvest Ophthalmol Vis Sci2006474254426117003413
   PubMed Web of Science ®Google Scholar
• TopouzisFColemanALHarrisAFactors associated with undiagnosed open-angle glaucoma: the Thessaloniki Eye StudyAm J Ophthalmol200814532733518045565
   PubMed Web of Science ®Google Scholar
• BurrJMMowattGHernándezRThe clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluationHealth Technol Assess20071141iiiivixx1190
   PubMed Web of Science ®Google Scholar
• Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension Costing Report, Implementing NICE guidance. NICE clinical guideline 85,42009
   Google Scholar
• An analysis of the costs of visual impairment and blindness in the United Kingdom issued by the Guide Dogs for the Blind Association http://www.healthyeyes.org.uk/index.php?id=35#894. Accessed August 13, 2010.
   Google Scholar
• KobeltGJonssonLGerdthamUKrieglsteinGKDirect costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in GermanyGraefes Arch Clin Exp Ophthalmol19982368118219825256
   PubMed Web of Science ®Google Scholar
• DenisPLafumaABerdeauxGMedical predictive factors of glaucoma treatment costsJ Glaucoma20041328329015226656
   PubMed Web of Science ®Google Scholar
• JönssonBKrieglsteinGPrimary open-angle glaucoma-differences in international treatment patterns and costsOxfordIsis Medical Media LTTT1998
   Google Scholar
• KoonerKSZimmermanTJThe cost of antiglaucoma medicationsAnn Ophthalmol1987193273283116907
   PubMed Web of Science ®Google Scholar
• BaudouinCRoulandJFLe PenCChanges in medical and surgical treatments of glaucoma between 1997 and 2000 in FranceEur J Ophthalmol200313Suppl 4S53S6012948053
   PubMed Web of Science ®Google Scholar
• Van der ValkRSchoutenJSWebersCAThe impact of a nationwide introduction of new drugs and a treatment protocol for glaucoma on the number of glaucoma surgeriesJ Glaucoma20051423924215870608
   PubMed Web of Science ®Google Scholar
• Nice GuidanceGlaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension http://guidance.nice.org.uk/CG85/. Accessed August 13, 2010.
   Google Scholar
• DenisPLafumaAKhoshnoodBA meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapyCurr Med Res Opin20072360160817355741
   PubMed Web of Science ®Google Scholar
• DenisPhLaunoisRDevauxMBerdeauxGComparison of diurnal Intraocular pressure control by latanoprost versus travoprost: results of an observational surveyClin Drug Investig200626703714
   PubMed Web of Science ®Google Scholar
• DenisPLafumaAJeanbatVIntraocular pressure control with latanoprost/timolol and travoprost/timolol fixed combinations: a retrospective, multicenter, cross-sectional studyClin Drug Investig200828767776
   PubMed Web of Science ®Google Scholar
• DenisPLe PenCUmuhireDTreatment carryover impacts on effectiveness of intraocular pressure lowering agents, estimated by a discrete event simulation modelEur J Ophthalmol200818445118203084
   PubMed Web of Science ®Google Scholar
• NetlandPALandryTSullivanEKTravoprost Study GroupTravoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertensionAm J Ophthalmol200113247248411589866
   PubMed Web of Science ®Google Scholar
• TopouzisFMelamedSDanesh-MeyerHA 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertensionEur J Ophthalmol20071718319017415690
   PubMed Web of Science ®Google Scholar
• HjelmgrenJBerggrenFAnderssonDHealth Economics guidelines – Similarities, differences and some implicationsValue Health2001422525011705185
   PubMedGoogle Scholar
• CovertDRobinALAdjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprostCurr Med Res Opin20062297197616709319
   PubMed Web of Science ®Google Scholar
• Deschaseaux-VoinetCLafumaABerdeauxGCost and effectiveness of brinzolamide versus dorzolamide in current practice: an analysis based on the UK-GPRD data baseJ Med Econom200366978
   Google Scholar
• WilenskyJFiscellaRGCarlsonAMMeasurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims dataAm J Ophthalmol20061411 SupplS28S3316389058
   PubMed Web of Science ®Google Scholar
• NordstromBLFriedmanDSMozaffariEPersistence and adherence with topical glaucoma therapyAm J Ophthalmol200514059860616226511
   PubMed Web of Science ®Google Scholar
• General Practice Research Database http://www.gprd.com/home/. Accessed on July 9, 2011.
   Google Scholar
• British Medical AssociationBritish National Formulary (BNF), No. 56LondonBritish Medical Association and the Royal Pharmaceutical Society of Great Britain92008
   Google Scholar
• Department of HealthElective spell HRG Tariff 2009/10London, UKNHS
   Google Scholar
• Department of HealthNHS Reference costs 2006 http://www.dh.gov.uk/en/index.htm. Accessed August 13, 2010.
   Google Scholar
• CurtisLUnit Costs of Health and Social Care 2007Canterbury, UKPSSRU Personal Social Services Research Unit2007
   Google Scholar
• CurtisLNettenAUnits costs of health and social care 2005 PSSRU University of Kent http://www.pssru.ac.uk/. Accessed August 13, 2010.
   Google Scholar
• BergströmAMaurelFLe PenCDaily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and SwedenClin Ophthalmol2009347148119714225
   PubMedGoogle Scholar
• StoneJLRobinALNovackGDAn objective evaluation of eyedrop instillation in patients with glaucomaArch Ophthalmol200912773273619506189
   PubMed Web of Science ®Google Scholar